BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23475581)

  • 1. Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis.
    Gupte AA; Lyon CJ; Hsueh WA
    Curr Diab Rep; 2013 Jun; 13(3):362-71. PubMed ID: 23475581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
    Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
    Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways.
    Shih PH; Hwang SL; Yeh CT; Yen GC
    J Agric Food Chem; 2012 Mar; 60(11):2924-33. PubMed ID: 22364184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does hepatic oxidative stress enhance activation of nuclear factor-E2-related factor in patients with nonalcoholic steatohepatitis?
    Takahashi Y; Kobayashi Y; Kawata K; Kawamura K; Sumiyoshi S; Noritake H; Watanabe S; Chida T; Souda K; Sakaguchi T; Nakamura H; Suda T
    Antioxid Redox Signal; 2014 Jan; 20(3):538-43. PubMed ID: 23822105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.
    Chen X; Xue H; Fang W; Chen K; Chen S; Yang W; Shen T; Chen X; Zhang P; Ling W
    Redox Biol; 2019 Feb; 21():101068. PubMed ID: 30684890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3β.
    Song JS; Kim EK; Choi YW; Oh WK; Kim YM
    Toxicol Appl Pharmacol; 2016 Sep; 307():138-149. PubMed ID: 27511913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Li J; Sapper TN; Mah E; Rudraiah S; Schill KE; Chitchumroonchokchai C; Moller MV; McDonald JD; Rohrer PR; Manautou JE; Bruno RS
    Mol Nutr Food Res; 2016 Apr; 60(4):858-70. PubMed ID: 26679056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Nrf2 in chronic liver disease.
    Tang W; Jiang YF; Ponnusamy M; Diallo M
    World J Gastroenterol; 2014 Sep; 20(36):13079-87. PubMed ID: 25278702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related Factors in Nonalcoholic Steatohepatitis Rats.
    Wang DJ; Cai YQ; Pan SZ; Zhang LZ; Chen YX; Chen FM; Jin M; Yan MX; Li XD; Chen ZY
    Chin J Integr Med; 2018 Apr; 24(4):265-271. PubMed ID: 26919834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect?
    Li B; Wang L; Lu Q; Da W
    Ir J Med Sci; 2016 Feb; 185(1):93-100. PubMed ID: 25385666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart.
    Jakobs P; Serbulea V; Leitinger N; Eckers A; Haendeler J
    Antioxid Redox Signal; 2017 Apr; 26(12):630-644. PubMed ID: 27923281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
    Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
    Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.
    Chambel SS; Santos-Gonçalves A; Duarte TL
    Biomed Res Int; 2015; 2015():597134. PubMed ID: 26120584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
    Ka SO; Bang IH; Bae EJ; Park BH
    FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
    Yang JJ; Tao H; Huang C; Li J
    Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction.
    Xu L; Nagata N; Ota T
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
    Okada K; Warabi E; Sugimoto H; Horie M; Tokushige K; Ueda T; Harada N; Taguchi K; Hashimoto E; Itoh K; Ishii T; Utsunomiya H; Yamamoto M; Shoda J
    J Gastroenterol; 2012 Aug; 47(8):924-35. PubMed ID: 22367278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation.
    Wu S; Yano S; Hisanaga A; He X; He J; Sakao K; Hou DX
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27935258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.